Table 2.
Correlation of rocuronium with birth statistics and serum analytes.
Intubating Rocuronium Dose | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Measure | Reference Range | Control | Cerebral Palsy Not on CAT | Cerebral Palsy on CAT | |||||||||
n | Mean ± SEM | Pearson r | p Value | n | Mean ± SEM | Pearson r | p Value | n | Mean ± SEM | Pearson r | p Value | ||
BW (kg) 1 | 2.5–4.0 | 44 | 3.53 ± 0.10 | −0.166 | 0.281 | 24 | 1.58 ± 0.18 | 0.544 | 0.006 ** | 29 | 2.58 ± 0.22 | 0.160 | 0.408 |
GA (weeks) 1 | 37–40 | 58 | 39.3 ± 0.31 | −0.142 | 0.289 | 30 | 32.0 ± 0.90 | 0.416 | 0.022 * | 32 | 35.3 ± 1.13 | 0.247 | 0.173 |
BW-by-GA | 0.07–0.10 | 42 | 0.09 ± 0.00 | −0.148 | 0.35 | 24 | 0.05 ± 0.00 | 0.510 | 0.011 * | 29 | 0.07 ± 0.00 | 0.117 | 0.545 |
Serum ALT 2 | 0–35 U/L | 0 | NA | NA | NA | 14 | 25.4 ± 2.10 | 0.286 | 0.322 | 29 | 26.8 ± 2.49 | 0.283 | 0.136 |
Serum Bilirubin 2 | 0.3–1.2 mg/dL | 0 | NA | NA | NA | 14 | 0.54 ± 0.08 | −0.062 | 0.833 | 29 | 0.27 ± 0.03 | −0.153 | 0.427 |
Serum Mg 2 | 1.5–2.4 mg/dL | 19 | 2.92 ± 0.19 | 0.255 | 0.291 | 4 | 3.27 ± 0.25 | 0.117 | 0.883 | 13 | 3.23 ± 0.30 | −0.219 | 0.473 |
Serum Tri 2 | <250 mg/dL | 19 | 56.9 ± 11.1 | −0.042 | 0.864 | 4 | 19.6 ± 10.3 | −0.768 | 0.232 | 13 | 24.6 ± 6.60 | 0.032 | 0.918 |
Total Rocuronium Dose | |||||||||||||
Measure | Reference Range | Control | Cerebral Palsy Not on CAT | Cerebral Palsy on CAT | |||||||||
n | Mean ± SEM | Pearson r | p Value | n | Mean ± SEM | Pearson r | p Value | n | Mean ± SEM | Pearson r | p Value | ||
BW (kg) 1 | 2.5–4.0 | 44 | 3.53 ± 0.10 | −0.166 | 0.281 | 24 | 1.58 ± 0.18 | 0.581 | 0.003 ** | 29 | 2.58 ± 0.22 | 0.160 | 0.408 |
GA (weeks) 1 | 37–40 | 58 | 39.3 ± 0.31 | −0.142 | 0.289 | 30 | 32.0 ± 0.90 | 0.432 | 0.017 * | 32 | 35.3 ± 1.13 | 0.247 | 0.173 |
BW-by-GA | 0.07–0.10 | 42 | 0.09 ± 0.00 | −0.148 | 0.35 | 24 | 0.05 ± 0.00 | 0.555 | 0.005 ** | 29 | 0.07 ± 0.00 | 0.117 | 0.545 |
Serum ALT 2 | 0–35 U/L | 0 | NA | NA | NA | 14 | 25.4 ± 2.10 | 0.287 | 0.320 | 29 | 26.8 ± 2.49 | 0.454 | 0.013 * |
Serum Bilirubin 2 | 0.3–1.2 mg/dL | 0 | NA | NA | NA | 14 | 0.54 ± 0.08 | −0.154 | 0.600 | 29 | 0.27 ± 0.03 | 0.040 | 0.837 |
Serum Mg 2 | 1.5–2.4 mg/dL | 19 | 2.92 ± 0.19 | 0.259 | 0.285 | 4 | 3.27 ± 0.25 | −0.573 | 0.427 | 13 | 3.23 ± 0.30 | −0.051 | 0.869 |
Serum Tri 2 | <250 mg/dL | 19 | 56.9 ± 11.1 | 0.016 | 0.948 | 4 | 19.6 ± 10.3 | −0.260 | 0.740 | 13 | 24.6 ± 6.60 | −0.324 | 0.279 |
1 Nemours Kids Health, 2 Merck Manual; Pearson r statistic, p < 0.05 = *, p < 0.01 = **. Abbreviations: CAT = Chronic Anticonvulsant Therapy; SEM = Standard Error of Measurement; BW = Birth Weight; GA = Gestational Age; ALT = Alanine Transaminase; Mg = Magnesium; Tri = Triglycerides.